Ipamorelin reverses postoperative gastric paralysis in rats, accelerating gastric emptying by activating ghrelin receptors.
Background
Delayed gastric emptying, or gastroparesis, is a common and debilitating disorder, particularly following abdominal surgery (postoperative ileus), with very few effective therapeutic options. This condition significantly impairs patient recovery and quality of life. The gut hormone ghrelin is known to stimulate gastric motility, making its receptor a promising target for prokinetic drugs. Ipamorelin is a synthetic peptidomimetic that specifically acts as an agonist on the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHSR). This study aimed to investigate whether ipamorelin could leverage this ghrelin receptor-mediated mechanism to restore normal gastric function in a validated animal model of postoperative gastric dysmotility.
Study Design
Fasted adult male rats underwent laparotomy and intestinal manipulation to induce a state of postoperative ileus. Immediately following surgery, one group of rats received a single intravenous administration of ipamorelin (0.014 µmol/kg or 0.14 µmol/kg) or a vehicle control. Gastric emptying was the primary endpoint, measured 15 minutes after intragastric gavage of a radioactive tracer ((99m)Tc sulfur colloid in methylcellulose). In a separate ex vivo experiment, gastric fundus tissue from similarly operated rats was isolated and suspended in an organ bath to assess the direct effect of ipamorelin (1 µM) on smooth muscle contractility induced by acetylcholine and electrical field stimulation.
Results
Abdominal surgery successfully induced delayed gastric emptying, with vehicle-treated control rats retaining 78% ± 5% of the meal in their stomachs. In stark contrast, a single intravenous dose of ipamorelin (0.014 µmol/kg) significantly accelerated gastric emptying. The surgery-induced inhibition of gastric smooth muscle contractility, observed in response to both acetylcholine and electrical field stimulation, was markedly reversed by the application of ipamorelin and ghrelin in isolated tissue preparations. This suggests a direct pro-contractile effect on the stomach muscle tissue. The conclusion drawn is that ipamorelin's prokinetic effects are mediated through the stimulation of gastric contractility via a ghrelin receptor-dependent mechanism that likely involves cholinergic excitatory neurons.
Post-surgery rats treated with ipamorelin retained only 52% ± 11% of the meal, a significant improvement (P < 0.05 vs vehicle) that approached the levels seen in non-surgical controls (44% ± 6%).
Key Findings
- Ipamorelin (0.014 µmol/kg, IV) significantly accelerated gastric emptying in a rat model of postoperative ileus (P < 0.05).
- Post-surgery, ipamorelin-treated rats had 52% ± 11% of a meal remaining in the stomach, compared to 78% ± 5% in vehicle controls.
- The gastric retention in ipamorelin-treated rats (52%) was close to that of non-surgical controls (44% ± 6%).
- Ipamorelin reversed the surgery-induced inhibition of gastric smooth muscle contractions in isolated tissue preparations.
- The mechanism is believed to involve activation of ghrelin receptors on cholinergic excitatory neurons.
Why It Matters
These findings position ipamorelin as a potential therapeutic agent for managing postoperative ileus, a condition that complicates recovery from abdominal surgery. For individuals using peptides, this highlights a specific, non-growth-related application for a ghrelin receptor agonist, particularly in a post-surgical context to restore gut motility. The study provides a mechanistic basis for its action, suggesting it directly restores the stomach's ability to contract. While promising, this is a preclinical rodent study. Human trials would be necessary to establish safety, effective dosing, and clinical efficacy in patients. However, the data strongly supports ipamorelin's role as a potent prokinetic agent worthy of further investigation for gastrointestinal dysmotility disorders.
